Fullerene Derivatives as Lung Cancer Cell Inhibitors: Investigation of Potential Descriptors Using QSAR Approaches.

Hung-Jin HuangOlga A KraevayaIlya I VoronovPavel A TroshinShan-Hui Hsu

Published in: International journal of nanomedicine (2020)

The guidelines obtained from the QSAR model might strongly facilitate the rational design of potential fullerene-based drug candidates for lung cancer therapy in the future.

Keyphrases

cancer therapy
molecular docking
molecular dynamics
drug delivery
single cell
cell therapy
human health
stem cells
structure activity relationship
emergency department
risk assessment
mesenchymal stem cells
bone marrow
drug induced
adverse drug
molecular dynamics simulations
electronic health record